News
Align Technology, Inc. ("Align") (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells ...
Our fair value estimate is $20.50 per share. Our long-term sales assumption relies on continued innovation from the firm—which allocates 4% of sales to research and development—as well as long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results